1. Han, Bing, He, Yiwen, Zhu, Min, Yi, Honggang, Tang, Shaowen. 2024. Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti-Tuberculosis Drug-Induced Liver Injury. In Journal of clinical pharmacology, 65, 197-205. doi:10.1002/jcph.6137. https://pubmed.ncbi.nlm.nih.gov/39297668/
2. Oliveri, Leda M, Davio, Carlos, Batlle, Alcira M del C, Gerez, Esther N. . ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice. In The Biochemical journal, 442, 303-10. doi:10.1042/BJ20111005. https://pubmed.ncbi.nlm.nih.gov/22070747/
3. Zhao, Yalei, Zhang, Xiaoyun, Liu, Yabin, Han, Mei, Li, Binghui. . Inhibition of ALAS1 activity exerts anti-tumour effects on colorectal cancer in vitro. In Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 26, 144-152. doi:10.4103/sjg.SJG_477_19. https://pubmed.ncbi.nlm.nih.gov/32270771/
4. Fraser, David J, Podvinec, Michael, Kaufmann, Michel R, Meyer, Urs A. 2002. Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR). In The Journal of biological chemistry, 277, 34717-26. doi:. https://pubmed.ncbi.nlm.nih.gov/12121995/
智鼠故事 
